A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)

BACKGROUND. The Cancer and Leukemia Group B (CALGB) conducted a phase II study evaluating sunitinib in patients with progressive metastatic pancreas adenocarcinoma following prior gemcitabine-based therapy (trial CALGB 80603; ClinicalTrials.gov identifier, NCT00397787). The primary endpoint was to d...

詳細記述

保存先:
書誌詳細
主要な著者: O'Reilly, Eileen M., Niedzwiecki, Donna, Hall, Margaret, Hollis, Donna, Bekaii-Saab, Tanios, Pluard, Timothy, Douglas, Kathe, Abou-Alfa, Ghassan K., Kindler, Hedy L., Schilsky, Richard L., Goldberg, Richard M.
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2010
主題:
Gastrointestinal Cancer
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227926/
https://ncbi.nlm.nih.gov/pubmed/21148613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0152
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料